These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Foscarnet activity on human immunodeficiency virus type 1 in the central nervous system. Delforge ML; Farber CM; De Leener F; Caroyer JM; Liesnard C; Van Vooren JP Clin Infect Dis; 1999 Apr; 28(4):931. PubMed ID: 10825078 [No Abstract] [Full Text] [Related]
4. HIV encephalitis in a patient on antiretroviral therapy: a case report. Hlebowicz M; Parczewski M; Jakubowski P Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753 [TBL] [Abstract][Full Text] [Related]
5. Viral escape in cerebrospinal fluid--an achilles heel of HIV therapy? Clifford DB J Infect Dis; 2010 Dec; 202(12):1768-9. PubMed ID: 21050117 [No Abstract] [Full Text] [Related]
6. HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia. Hengge UR; Brockmeyer NH; Esser S; Maschke M; Goos M AIDS; 1998 May; 12(7):818-20. PubMed ID: 9619817 [No Abstract] [Full Text] [Related]
7. [Not only plasma viral load counts. HIV can also be latent in the brain]. MMW Fortschr Med; 2001 Nov; 143(48):58. PubMed ID: 11770381 [No Abstract] [Full Text] [Related]
8. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Bingham R; Ahmed N; Rangi P; Johnson M; Tyrer M; Green J Int J STD AIDS; 2011 Oct; 22(10):608-9. PubMed ID: 21998185 [TBL] [Abstract][Full Text] [Related]
9. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalopathy. Di Stefano M; Monno L; Ramon Fiore J; Angarano G AIDS; 1997 Apr; 11(5):698-9. PubMed ID: 9108963 [No Abstract] [Full Text] [Related]
10. Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms. Kugathasan R; Collier DA; Haddow LJ; El Bouzidi K; Edwards SG; Cartledge JD; Miller RF; Gupta RK Clin Infect Dis; 2017 Apr; 64(8):1059-1065. PubMed ID: 28329096 [TBL] [Abstract][Full Text] [Related]
11. 1592: two studies recruiting. AIDS Treat News; 1996 Nov; (No 259):3, 6. PubMed ID: 11364000 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment. Goodkin K; Vitiello B; Lyman WD; Asthana D; Atkinson JH; Heseltine PN; Molina R; Zheng W; Khamis I; Wilkie FL; Shapshak P J Neurovirol; 2006 Jun; 12(3):178-89. PubMed ID: 16877299 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid HIV viral load may be detectable, despite serum viral load being undetectable, in patients diagnosed with syphilis. Muldoon EG; Coughlan S; Mulcahy F Sex Transm Infect; 2012 Nov; 88(7):480. PubMed ID: 22679100 [No Abstract] [Full Text] [Related]
15. HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy. Guerveno C; Raymond S; Metsu D; Gandia P; Izopet J; Martin-Blondel G; Delobel P AIDS; 2019 Mar; 33(3):593-594. PubMed ID: 30702524 [No Abstract] [Full Text] [Related]
16. Impact of current antiretroviral therapies on neuroAIDS. Vivithanaporn P; Gill MJ; Power C Expert Rev Anti Infect Ther; 2011 Apr; 9(4):371-4. PubMed ID: 21504390 [No Abstract] [Full Text] [Related]
17. Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients. Calcagno A; Bonora S; Bertucci R; Lucchini A; D'Avolio A; Di Perri G AIDS; 2010 Mar; 24(6):931-2. PubMed ID: 20234194 [No Abstract] [Full Text] [Related]
18. Neurobehavioral manifestations and sequelae of HIV and other infections. Pontrelli L; Pavlakis S; Krilov LR Child Adolesc Psychiatr Clin N Am; 1999 Oct; 8(4):869-78. PubMed ID: 10553208 [TBL] [Abstract][Full Text] [Related]
19. Comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid". Calcagno A; D'Avolio A; Di Perri G; Bonora S J Acquir Immune Defic Syndr; 2013 Apr; 62(4):e118-9. PubMed ID: 24135736 [No Abstract] [Full Text] [Related]
20. Response to Calcagno comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid". Cusini A; Ledergerber B; Widmer N; Günthard HF J Acquir Immune Defic Syndr; 2013 Oct; 64(2):e14-5. PubMed ID: 24047974 [No Abstract] [Full Text] [Related] [Next] [New Search]